Analysis of Body Mass Index, Waist Circumference, and Body Fat in Predicting Insulin Resistance of Polycystic Ovary Syndrome

被引:0
作者
Harzif, Achmad Kemal [1 ]
Yusuf, Dwiyanarsi [1 ]
Silvia, Melisa [1 ]
Wiweko, Budi [1 ]
Hestiantoro, Andon [1 ]
机构
[1] Univ Indonesia, Dept Obstet & Gynecol, Subfertil & Immunoendocrinol Div, Depok, Indonesia
关键词
Body Mass Index; Waist Circumference; Body Fat; Insulin Resistance; PCOS; WOMEN;
D O I
10.1166/asl.2017.9403
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Polycystic Ovary Syndrome (PCOS) can be found in 5-10% women in reproductive age. Insulin resistance plays role in 50-80% PCOS patients. Many methods of measurement has been established to determine insulin resistance. However, all method of measurements are invasive, expensive, and inaccessible in remote area. Objectives: To assess whether Body Mass Index (BMI), waist circumference and body fat can be used as predicting variables of insulin resistance in PCOS patients and to assess variables' cut off point. Method: This was a cross-sectional study of BMI, waist circumference, and body fat to assess insulin resistance in PCOS patients. A diagnostic study with observations that can be a predictor of insulin resistance in PCOS patients. Samples of this study were 61 women with PCOS. Results: There were 47 subjects (77%) with insulin resistance and 14 subjects (23%) who were not insulin resistance. All of three variables were statistically significant, there were BMI (p = 0.001, cut-off point value = 24.75 kg/m(2), sensitivity = 72.3%, and specificity = 71.4%), waist circumference (p = 0.004, cut off point value = 86.5 cm, sensitivity = 68.1%, and specificity = 71.4%), and body fat (p = 0.005, cut-off point value = 36.15%, sensitivity = 68.1%, and specificity = 64.3%). Conclusion: BMI, waist circumference and body fat can be used as predictors of insulin resistance in PCOS women.
引用
收藏
页码:6807 / 6810
页数:4
相关论文
共 20 条
  • [1] [Anonymous], 2015, HLTH JHFWS EVIDENCE
  • [2] Balen H. A., 2005, POLYCYSTIC OVARY SYN
  • [3] Stress in women - Metabolic syndrome and polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Economou, Frangiskos
    [J]. STRESS, OBESITY, AND METABOLIC SYNDROME, 2006, 1083 : 54 - 62
  • [4] Medical progress: Polycystic ovary syndrome
    Ehrmann, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) : 1223 - 1236
  • [5] Abdominal adiposity and the polycystic ovary syndrome
    Escobar-Morreale, Hector F.
    Millan, Jose L. San
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2007, 18 (07) : 266 - 272
  • [6] Prediction models for insulin resistance in the polycystic ovary syndrome
    Gennarelli, G
    Holte, J
    Berglund, L
    Berne, C
    Massobrio, M
    Lithell, H
    [J]. HUMAN REPRODUCTION, 2000, 15 (10) : 2098 - 2102
  • [7] Assessment of insulin resistance in young women with polycystic ovary syndrome
    Jensterle, Mojca
    Weber, Matthias
    Pfeifer, Marija
    Prezelj, Janez
    Pfutzner, Andreas
    Janez, Andrej
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 102 (02) : 137 - 140
  • [8] Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study
    Knochenhauer, ES
    Key, TJ
    Kahsar-Miller, M
    Waggoner, W
    Boots, LR
    Azziz, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) : 3078 - 3082
  • [9] Luhas C. I., 2013, ROM J DIABETES NUTR, V20, P107
  • [10] Should all women with PCOS be treated for insulin resistance?
    Marshall, John C.
    Dunaif, Andrea
    [J]. FERTILITY AND STERILITY, 2012, 97 (01) : 18 - 22